Obstructive sleep apnoea syndrome in patients living with diabetes: which patients should be screened? - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Journal of Diabetes & Metabolism Année : 2019

Obstructive sleep apnoea syndrome in patients living with diabetes: which patients should be screened?

Philip Böhme
  • Fonction : Auteur

Résumé

Because type 2 diabetes (T2D) is related to obesity, it is often associated with obstructive sleep apnoea syndrome (OSAS), although OSAS is also frequently diagnosed in patients with type 1 diabetes (T1D) and may promote gestational diabetes. Thus, this systematic review of the scientific evidence aimed to evaluate the epidemiological association between OSAS and all forms of diabetes, the current understanding of the pathophysiological mechanisms behind these associations, the expected benefits and limitations of OSAS treatment in patients with diabetes and, finally, to propose which patients require screening for OSAS.
Fichier principal
Vignette du fichier
2018 Borel et al., Obstructive sleep.pdf (54.85 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01870370 , version 1 (02-01-2020)

Identifiants

Citer

Anne-Laure Borel, Renaud Tamisier, Philip Böhme, Pascaline Priou, Antoine Avignon, et al.. Obstructive sleep apnoea syndrome in patients living with diabetes: which patients should be screened?. Journal of Diabetes & Metabolism, 2019, 45 (2), pp.91-101. ⟨10.1016/j.diabet.2018.08.006⟩. ⟨hal-01870370⟩
368 Consultations
432 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More